Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Jun 3;65(6):25.
doi: 10.1167/iovs.65.6.25.

Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy

Francesco Testa  1 , Ester Carreño  2 , L Ingeborgh van den Born  3 , Paolo Melillo  1 , Irene Perea-Romero  4   5 , Valentina Di Iorio  1 , Giulia Risca  6 , Clemente Maria Iodice  1 , Ronald J E Pennings  7 , Marianthi Karali  1   8 , Sandro Banfi  8   9 , Alberto Auricchio  9   10   11 , Stefania Galimberti  6 , Carmen Ayuso  4   5 , Francesca Simonelli  1
Affiliations
Multicenter Study

Multicentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy

Francesco Testa et al. Invest Ophthalmol Vis Sci. .

Abstract

Purpose: We investigated the natural history of retinal dystrophy owing to variants in the MYO7A gene.

Methods: Fifty-three patients (mean age, 33.6 ± 16.7 years) with Usher syndrome owing to biallelic, mostly pathogenic, variants in MYO7A underwent baseline and two annual follow-up visits. Best-corrected visual acuity (BCVA), semiautomatic kinetic visual field, full-field electroretinogram, color fundus imaging, microperimetry, spectral-domain optical coherence tomography, and fundus autofluorescence were assessed.

Results: At baseline, all patients presented with decreased BCVA (66.4 ± 17.9 Early Treatment Diabetic Retinopathy score and 59.5 ± 21.7 Early Treatment Diabetic Retinopathy score, in the better- and worse-seeing eyes, respectively), restricted semiautomatic kinetic visual field (III4e area, 3365.8 ± 4142.1°2; 4176.4 ± 4400.3°2) and decreased macular sensitivity (9.7 ± 9.9 dB; 9.0 ± 10.2 dB). Spectral-domain optical coherence tomography revealed reduced central macular thickness (259.6 ± 63.0 µm; 250.7 ± 63.3 µm) and narrowed ellipsoid zone band width (2807.5 ± 2374.6 µm; 2615.5 ± 2370.4 µm). Longitudinal analyses (50 patients) showed a significant decrease of BCVA in better-seeing eyes, whereas no changes were observed in worse-seeing eyes for any parameter. BCVA, semiautomatic kinetic visual field (III4e and V4e) and macular sensitivity were related significantly to age at baseline. Hyperautofluorescent foveal patch (16 eyes [31.4%]) and abnormal central hypoautofluorescence (9 eyes [17.6%]) were significantly associated with worse morphological and functional read-outs compared with the hyperautofluorescent ring pattern (22 eyes [43.1%]).

Conclusions: Our European multicentric study offers the first prospective longitudinal analysis in one of the largest cohorts of MYO7A patients described to date, confirming the slow disease progression. More important, this study emphasizes the key role of fundus autofluorescence patterns in retinal impairment staging and advocates its adoption as an objective biomarker in patient selection for future gene therapy clinical trials.

PubMed Disclaimer

Conflict of interest statement

Disclosure: F. Testa, None; E. Carreño, None; L.I. van den Born, None; P. Melillo, None; I. Perea-Romero, None; V. Di Iorio, None; G. Risca, None; C.M. Iodice, None; R.J.E. Pennings, None; M. Karali, None; S. Banfi, None; A. Auricchio, None; S. Galimberti, None; C. Ayuso, None; F. Simonelli, None

Figures

Figure.
Figure.
Comparison of SKVF and SD-OCT in three selected patients with different FAF patterns. FAF shows the three most common patterns: hyperautofluorescent ring (a), hyperautofluorescent foveal patch (b), and abnormal central hypoautofluorescence (c). SKVF in the cases with hyperautofluorescent foveal patch (e) and with abnormal central hypoautofluorescence (f) show a more restricted area compared with the case with hyperautofluorescent ring (d). SD-OCT scans show a slightly reduced CMT with preserved EZ band in the case with hyperautofluorescent ring (g), markedly decreased CMT with disrupted EZ band in the case with hyperautofluorescent foveal patch (h), and markedly reduced CMT without detectable EZ band in the case with abnormal central hypoautofluorescence (i).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Millán JM, Aller E, Jaijo T, Blanco-Kelly F, Gimenez-Pardo A, Ayuso C.. An update on the genetics of Usher syndrome. J Ophthalmol. 2011; 2011: 1–8. - PMC - PubMed
    1. Kremer H, van Wijk E, Märker T, Wolfrum U, Roepman R.. Usher syndrome: molecular links of pathogenesis, proteins and pathways. Hum Mol Genet. 2006; 15(Suppl. 2): R262–270. - PubMed
    1. Boughman JA, Vernon M, Shaver KA.. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis. 1983; 36(8): 595–603. - PubMed
    1. Hartong DT, Berson EL, Dryja TP.. Retinitis pigmentosa. Lancet. 2006; 368(9549): 1795–1809. - PubMed
    1. Khateb S, Mohand-Saïd S, Nassisi M, et al. .. Phenotypic characteristics of rod-cone dystrophy associated with myo7a mutations in a large French cohort. Retina. 2020; 40(8): 1603–1615. - PubMed

Publication types

MeSH terms

-